HFA 2021

Late-Breaking Trials

Iron substitution improves LVEF in intensively treated CRT patients with iron deficiency

Presented By

Dr Pieter Martens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, IRON-CRT

Conference

HFA 2021

19 August, 2021 16:10

Novel mineralocorticoid receptor antagonist effective irrespective of HF history

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELIO-DKD

Conference

HFA 2021

19 August, 2021 16:05

Iron substitution in iron-deficient HF patients is highly cost-effective

Presented By

Prof. Phil McEwan, Swansea University, UK

Trial

AFFIRM-AHF

Conference

HFA 2021

19 August, 2021 15:59

Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter

Presented By

Prof. Scott Solomon, Brigham and Women’s Hospital, MA, USA

Trial

GALACTIC-HF

Conference

HFA 2021

19 August, 2021 15:52

Vericiguat effective irrespective of atrial fibrillation status

Presented By

Prof. Piotr Ponikowski, Wrocław Medical University, Poland

Trial

VICTORIA

Conference

HFA 2021

19 August, 2021 15:45

Baroreflex activation: a novel option to improve heart failure symptoms

Presented By

Prof. Andrew Coats, University of Warwick, UK

Trial

BEAT-HF; HOPE4HF

Conference

HFA 2021

19 August, 2021 15:35

Beta-blocker withdrawal to enhance exercise capacity in heart failure?

Presented By

Prof. Julio Nuñez Villota, University Clinical Hospital of Valencia, Spain

Trial

Phase 4, PRESERVE-HR

Conference

HFA 2021

19 August, 2021 15:29

Inconclusive results for dapagliflozin treatment in heart failure

Presented By

Prof. John McMurray, University of Glasgow, UK

Trial

DETERMINE-Reduced; DETERMINE-Preserved

Conference

HFA 2021

19 August, 2021 15:23

Computerised cognitive training improves cognitive function in HF patients

Presented By

Sonja Wedegärtner, Saarland University Hospital, Germany

Conference

HFA 2021

19 August, 2021 15:15

COVID-19 and the Heart

COVID-19-related HF: from systemic infection to cardiac inflammation

Presented By

Prof. Marco Metra, University of Brescia, Italy

Conference

HFA 2021

19 August, 2021 10:19

Increased COVID-19 mortality in patients with cardiorenal comorbidity

Presented By

Dr Johan Bodegård

Conference

HFA 2021

19 August, 2021 10:07

Myocardial infarction outcomes were significantly affected by the pandemic

Presented By

Dr Ayman Haq, Baylor University Medical Center, USA

Conference

HFA 2021

19 August, 2021 10:03

TAPSE effective biomarker associated with high-risk of severe COVID-19

Presented By

Dr Neil Bodagh, King´s College Hospital NHS Foundation Trust, UK

Conference

HFA 2021

19 August, 2021 09:38

COVID-19 in AF patients with HF: no higher mortality but longer hospital stay

Presented By

Prof. Bektaş Murat, Eskisehir Osmangazi University, Turkey

Conference

HFA 2021

19 August, 2021 09:38

Cancer and the Heart

Heart Failure Prevention and HRQoL in the 21st century

Psychoactive substances put young people at risk of cardiovascular disease

Presented By

Dr Vijay Chopra, Max Super Speciality Hospital Saket, India

Conference

HFA 2021

19 August, 2021 09:28

The challenge of improving the quality of life of heart failure patients

Presented By

Prof. Ileana L. Piña, Central Michigan University, USA

Trial

DAPA-HF; PROVE-HF

Conference

HFA 2021

19 August, 2021 09:20

SGLT2 Inhibitors in Heart Failure

Best of the Posters